FindTrial
Sign In

Use of a blood test (MDW) to detect and predict outcomes in patients with severe infection (sepsis)

Monocyte Distribution Width as a Diagnostic and Prognostic Biomarker of Sepsis - MDW-Sepsis Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/04/108272
Enrollment
194
Registered
2026-04-13
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: A419- Sepsis, unspecified organism

Interventions

Intervention1: Nil: Nil

Sponsors

KASTURBA MEDICAL COLLEGE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age more than 18 years Patients admitted to ICU with suspected infection Patients meeting Sepsis3 criteria

Exclusion criteria

Exclusion criteria: Patients with hematological malignancies Patients on immunosuppressive therapy Refusal to consent

Design outcomes

Primary

MeasureTime frame
Diagnostic accuracy of Monocyte Distribution Width (MDW) in identifying sepsisTimepoint: DAY 0 (AT ADMISSION) DAY 3 DAY 5—

Secondary

MeasureTime frame
Prognostic value of MDW in predicting patient outcomes (survivors vs non-survivors) Association of MDW with severity of illness Correlation of MDW with inflammatory markersTimepoint: DAY 0 (AT ADMISSION) DAY 3 DAY 5—

Countries

India

Contacts

Public ContactDrAmeya Lathi

Kasturba Medical College, Manipal

shreesha.n@manipal.edu7892882273

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026